Plus Therapeutics Partners With K2bio for Development of Novel Tests for Cerebrospinal Fluid (CSF) Tumor Cell and Molecular Biomarker Analyses
Stock Information for PLUS THERAPEUTICS Inc.
Loading
Please wait while we load your information from QuoteMedia.